Buy Intra-Cellular Therapies Stock | ITCI Stock Price & Latest News | Public
ITCI

Intra-Cellular Therapies

$0.00 (0.00%)Today

    About ITCI

    Intra-Cellular Therapies, Inc. is a biopharmaceutical company, which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular si...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.33
    -0.66
    -0.99
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.88

    Actual EPS
    Q4 2020

    Stats

    Market Cap$2,03B
    Volume2,88k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$43.56
    1 Year Low$8.27
    Open$25.64
    High$25.72
    Low$24.86

    Buy any stock with any amount of money.

    Download the App
    Download the app